Life-sciences venture capital firm founded in 2005, investing in therapeutics, biotech, biopharma (70%), medical devices (20%), diagnostics (10%), focused on oncology, rare diseases, AI-driven drug discovery.
Create a free account to see deal history, investment amounts, and round details.
Create Free Account